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http://www.biomedcentral.com/1471-2369/13/154RESEARCH ARTICLE Open AccessClinician’s use of automated reports of estimated
glomerular filtration rate: A qualitative study
David H Smith1*, Jennifer Schneider1, Micah L Thorp1,2, Suma Vupputuri3, Jessica W Weiss1,4, Eric S Johnson1,
Adrianne Feldstein1, Amanda F Petrik1, Xuihai Yang1 and Susan R Snyder5Background: There is a growing awareness in primary care of the importance of identifying patients with chronic
kidney disease (CKD) so that they can receive appropriate clinical care; one method that has been widely embraced
is the use of automated reporting of estimated glomerular filtration rate (eGFR) by clinical laboratories. We
undertook a qualitative study to examine how clinicians use eGFR in clinical decision making, patient
communication issues, barriers to use of eGFR, and suggestions to improve the clinical usefulness of eGFR reports.
Methods: Our study used qualitative methods with structured interviews among primary care clinicians including
both physicians and allied health providers, recruited from Kaiser Permanente Northwest, a non-profit health
maintenance organization.
Results: We found that clinicians generally held favorable views toward eGFR reporting but did not use eGFR to
replace serum creatinine in their clinical decision-making. Clinicians used eGFR as a tool to help identify CKD,
educate patients about their kidney function and make treatment decisions. Barriers noted by several clinicians
included a desire for greater education regarding care for patients with CKD and tools to facilitate discussion of
eGFR findings with patients.
Conclusions: The manner in which clinicians use eGFRs appears to be more complex than previously understood,
and our study illustrates some of the efforts that might be usefully undertaken (e.g. specific clinician education)
when encouraging further promulgation of eGFR reporting and usage.
Keywords: Estimated glomerular filtration rate, Qualitative, Serum creatinineBackground
Pre-dialysis chronic kidney disease (CKD) is a common
condition with an estimated prevalence of more than
13% of the US population [1]. But less than half of
patients with CKD are unaware they have it [2] or don’t
carry a diagnosis in their medical record [3], suggesting
low patient and provider awareness. Historically, serum
creatinine has been the principal way of assessing kidney
function. But serum creatinine is an imperfect method
of identifying diminished kidney function. The use of a
formula that includes serum creatinine age, sex, and race
produces an estimate of the kidney’s glomerular filtration
rate (eGFR) which improves the diagnostic accuracy over
serum creatinine alone. Recently, automated reporting of
patients’ eGFR by clinical laboratories has been promulgated* Correspondence: David.h.smith@kpchr.org
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reproduction in any medium, provided the oras a method for increasing CKD awareness and, therefore,
also improving appropriate treatment and follow-up.
For example, automated reporting of eGFR by clinical
laboratories has been encouraged to by the National
Kidney Foundation [4] and National Kidney Disease
Education Program [5] and is required by at least six
states [6].
Using eGFR has its own disadvantages, such as under-
estimating renal function in healthy individuals, leading to
increased false positive diagnoses [7]. Even so, a recent
systematic review found that automated eGFR reporting
was associated with changed care patterns, including
increased nephrology referrals and consultations [8]. But
as noted in that review it is unclear how eGFR reporting
may have caused those changes.
Many factors likely influence how health care provi-
ders use laboratory tests. For example, a provider’s
knowledge of the patient’s clinical situation, their reim-
bursement, and understanding of the sensitivity andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ordered and how it is interpreted and used clinically [9].
As a result, efforts to influence the laboratory ordering
patterns of physicians have met with varying success
[10,11]. Little is known about how clinicians (i.e. both
physicians and allied health care providers) understand
and respond to laboratory reports of renal function, or
whether they respond to and interpret eGFR differently
than serum creatinine. To help fill that gap we under-
took a qualitative study using structured interviews to en-
hance our understanding of how primary care clinicians
use eGFR in clinical decision making, patient communica-
tion issues, barriers to use of eGFR, and suggestions to
improve the clinical usefulness of eGFR.
Methods
Study site and systems
The study was conducted in 2010 (April through June)
at a nonprofit group-model health-maintenance organization
(HMO), Kaiser Permanente Northwest (KPNW), in
Washington and Oregon. The site has 15 medical cen-
ters and approximately 485,000 members. Electronic
databases provided administrative and clinical data and
a full electronic medical record (EMR) has been in
place since 1996. The study was approved by the insti-
tutional review board at KPNW and clinician partici-
pants provided written informed consent.
The EMR and related systems used at KPNW contain
several tools that clinicians can use to automate func-
tions. Several of these automated tools were referred to
by our participants so we give a brief description of
them here. The Panel Support Tool (PST) is a ‘dash-
board’ indicator of potential care gaps that are reported
at the patient level. For example, it reports on the
current status of testing and follow-up for patients with
diabetes, cardiovascular disease, asthma and CKD,
among other co-morbid conditions, and recommends
treatment and testing strategies to close the care gaps.
The EMR also allows the creation of ‘dot phrases’ that
can be used, for example, to automatically populate text
in clinical notes and in patient letters.
Estimated GFR (eGFR) reporting by laboratory
Our study was designed to take advantage of a systematic
change at KPNW where all laboratory locations began
automatically reporting eGFR routinely with serum cre-
atinine in its laboratory results to clinicians. This reporting
began on February 1, 2004. Prior to this, only the serum
creatinine value was reported to clinicians on laboratory
reports. The laboratory used the 4 variable version of the
Modification in Diet and Renal Disease (MDRD) Study
[12], which includes a binary variable for whether the
patient is black. Because race data were not available,
the laboratory reported eGFR values for both black andnon-black routinely with each serum creatinine result.
eGFR values above 60 ml/min/1.73 m2 were reported at
“>60”. No further comments or information was provided.
Qualitative methods
Qualitative methods are effective strategies for document-
ing and analyzing unique, complex social phenomena,
such as clinician experiences with a “newly” reported lab
value [13-15]. Qualitative data, such as interviews, can
reveal information unanticipated by researchers [16-18],
and may be key to helping us understand how clinicians’
are interacting with automatic reporting of the eGFR.
Additionally, individual interviews are designed to elicit
the participant’s perspective and experience on a topic,
and are therefore particularly useful in defining the range
and variability of beliefs, behaviors, and experiences of
study populations, as well as the natural language people
use to discuss these issues [13,14,19]. To this end, primary
care clinicians’ experiences of the automatic laboratory
reporting of the eGFR were captured and analyzed
through a series of 30 minute, structured, open-ended face
to face interviews.
Recruitment and study participants
We identified a list of 139 Family Practice (FP) or Internal
Medicine (IM) based primary care providers (PCPs) who
had been employed with KPNW from at least January 2002
to the present. This time frame was chosen so that clini-
cians could speak about their experiences of eGFR both be-
fore and after automatic reporting began in 2004. We
included clinicians who were either physicians (MD) or al-
lied health practitioners (NP or PA). We aimed to interview
a minimum of 16 PCPs, a number we determined as suffi-
cient for reaching redundancy of information and themes
based on prior experience with qualitative methods and
interviewing clinicians. Of these 16 clinicians, our goal was
to interview 8 allied health practitioners (distributed equally
between IM and FP), and 8 MDs (distributed equally be-
tween IM and FP). We also attempted to balance the parti-
cipants geographically across the 13 clinics. Clinicians were
recruited by email, sent by the Chief of Nephrology (co-
author MLT), inviting them to participate in a 30 minute
structured interview. Lunch was provided to the partici-
pants. We completed 19 in-depth individual interviews
with PCPs. Of these, 13 were MDs (8 IM, 5 FP) and 6
were allied health practitioners (2 IM, 4 FP). We sent 89
individual recruitment emails to reach this total, with 64
participants providing no response to the email and 6
participants indicating scheduling conflicts or lack of
time as their reason for not participating.
Data collection and analysis
The research team developed a structured guide (based
upon prior experience [16-18,20] and a literature review)
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With each participant we followed the interview guide,
which consisted of 15 key questions and approximately
45 follow up prompts. The guide elicited information
about clinicians’ overall reaction to the automatic report-
ing of the eGFR, barriers and facilitators to the use of
the eGFR, work practices related to the use of the eGFR,
and overall advice on how to improve it. Interviews were
conducted by a trained, third-party qualitative method-
ologist not known to the participants [co-author JS],
audio-recorded, and professionally transcribed for ana-
lysis. Analysis was led by co-author JS with guidance and
input from the research team. Analyses focused on
representing, describing, and interpreting data, using
standard techniques [15,19,21,22] and a qualitative re-
search software package, ATLAS.ti 5.0 (Scientific Soft-
ware Development, 1997) to code data and generate
reports of coded text for analysis. We developed a cod-
ing dictionary based on the interview guide and review
of the transcribed interviews. Transcribed interviews
were coded by marking passages of text with phrases in-
dicating content of the discussions. Using the report and
query functions of Atlas.ti, coded text was further
reviewed through an iterative process, resulting in
refined themes [22,23].
Results
We interviewed 19 clinicians, 10 in the department of
IM, 9 in the department of FP (Table 1). Thirteen of the
19 were physicians, 2 nurse practitioners and 4 physician
assistants. The average number of years that the clin-
ician participants worked at KPNW was 16.3 years for
physicians and 18.5 years for allied health practitioners.
The average panel sizes (i.e. number of patients assigned
to the clinician for health care management) were 1251
for the physicians and 1176 for the allied healthTable 1 Participant Demographics
PCP Allied* Totals
(n = 13) (n = 6) (n = 19)
Provider Type 8 IM; 5 FP 2 IM; 4 FP 10 IM; 9 FP
Yrs at KP** Range 2–30; Range 11–22;
Ave: 16.3 Ave: 18.5
Clinical Allocations 4 FTE; 9 PTE 4 FTE; 2 PTE
Panel Size Range 700–2044; Range 1000–1405;
Ave: 1251 Ave: 1176***
Other Roles**** 9 2
* 2 nurse practitioners; 4 physician assistants;
** Includes all clinicians with date of service from at least January 2002 to
present (gaps in employment permissible).
*** 2 Allied physicians without their own patient panel to manage.
**** Other roles include such things as: provider/resident education and
communication; urgent care; clinical director; team lead; health plan board
member; document and coding; recruitment and retention; and home health/
hospice work.practitioners. Eight clinicians worked full time and 11
part time. While our interviews occurred approximately
6 years after the 2004 initiation of automatic reporting
of eGFR, participants had no trouble recalling when the
shift to automatic reporting began, nor any hesitation
describing their reaction, feelings, or impact on work-
load both at the onset of the reporting and over time.
Clinician use of eGFR: before and after automated
reporting
We asked clinicians about their use of eGFR prior to,
and after, automated eGFR reporting was instituted.
About half of the physicians said they had, at least some-
times, calculated eGFR before the implementation of
automated reporting, while none of the allied health pro-
fessionals did so. In fact, all the clinicians said they had
primarily used serum creatinine as their gauge of kidney
health before automated reporting (Table 2).
When asked about whether their overall approach to
CKD management had changed since automated eGFR
reporting, more than half of the clinicians said that it
had. However, a minority said their overall approach had
not changed, and by clinician type, there seemed to be
little difference in whether management of CKD had
changed. We found that the majority of clinicians reported
currently using both eGFR and serum creatinine in clinical
decision-making. Only one clinician reported currently
using serum creatinine more often than eGFR.
Benefits and challenges of automated eGFR
Clinicians’ perceived benefits of automated eGFR included
time savings, increased disease awareness and improved
patient care. Clinicians mentioned that having the eGFR
calculated saved them valuable clinic time because it
streamlined their work and removed the need for calculat-
ing it themselves. For example an internal medicine clin-
ician commented (Table 3):
[Previously] I would very frequently have to look up
their kidney function and actually calculate the
GFR. . .So, definitely in an older population you
encounter that often with certain medications. When
automatic reporting came on, it was really helpful. I’ve
never calculated it since then, and I said to myself,
‘Oh, that’s so going to save me time!’.
Clinicians also discussed being appreciative of the in-
formation, and wished they’d had the information earlier
because there were patients in whom opportunities for
clinical intervention were previously missed. They said
eGFR, and the subsequent staging of CKD, gives them
a better picture of renal health than they could get
with serum creatinine alone. Clinicians mentioned that
their awareness of CKD was greater with eGFR being
Table 2 Comparison of Use of eGFR Value Prior to, and After, Automatic Reporting (n = 19)
Use of eGFR Value Before Automatic Reporting
Common Theme and Key Findings PCP Allied Totals Illustrative Quotes
(n = 13) (n = 6) (n = 19)
Provider Calculated eGFR Prior I would sometimes calculate it [eGFR]to see, but it wasn’t common. And that was generally if their creatinine wasn’t normal, just
so I’d have a better idea of how bad their GFR was. But I wouldn’t if they were older and they had a normal creatinine. – IM PCP• sometimes to occasionally 6 0 6
• rarely to never 7 6 13 No, I never calculated it [GFR]. . . I would just look at their creatinines and if they were elevated. . .. – FM NP
Provider Primarily Utilized Creatinine
• yes 13 6 19 . . . all I ever did [prior] was keep track of patients’ creatinines. – FM PCP
Use of eGFR Value After Automatic Reporting
Common Theme and Key Findings PCP Allied Totals Illustrative Quotes
(n = 13) (n = 6) (n = 19)
Changed Overall Approach to CKD
Management
There’s a number of folks [with Stage] 2 CKD . . ., I feel like it helps me manage them a lot better. –FM NP
• yes 8 4 12 Definitely it has shifted my clinical practice. . .I think I run less and less into trouble ordering certain medications. – IM PCP
• no / not much 5 2 7 It hasn’t necessarily changed my approach. . . It may have just labeled them as having now another problem. – IM PCP
Utilization of eGFR & Creatinine
Values in Decision-making
• uses both 11 4 15 Now I look at the trends in both creatinine and their GFR. And I do update in the patient’s problem list. . . - IM PCP
• uses eGFR more often 2 1 3 I do look at the trend of GFR, and that helps me, first of all, in updating the diagnosis or putting the diagnosis in the problem
list. . . It’s very helpful. So, yeah, I do look [eGFR] up a lot. – IM PCP



















Table 3 Overall Impact of eGFR Automatic Reporting: Benefits and Challenges (n = 19)
Benefits
Common Theme and Key Findings Illustrative Quotes
Time Savings I thought it was great [to have it automatically reported] cause I didn’t have to try to manually calculate it.
Prior I had been using kind of just ballpark numbers to tr guesstimate when I thought somebody’s renal
function was starting to decline and if I needed to adjust dication. So, it was challenging because it added
work to my day to have to manually do that or try to as that. . . So it has made life easier for me to have it
calculated. – FM PCP
• automatic calculation and reporting makes approach and work to CKD management
more streamlined
• easier to have eGFR calculated for provider - saves valuable clinic time to not calculate
equation on own when they need it
I think it’s a good tool. So the fewer steps that we have to to get to the right answer, and the right thing to
do, the better it is. I think the automatic calculator is quic and better at math than I am, and more reliable.
And so, it takes away some of the potential for error that ight have introduced by manually doing the
calculations myself. – IM PCP
Grateful for the Information Well, what it did was show that there were a lot of peop ith worse renal function than we had appreciated
previously based just on creatinine. . . . we started looking treatment of Stage 30s, . . .trying to put [them] on
ACE inhibitors. It wasn’t a usual practice until that [autom c reporting] happened. And without [automatic
reporting], it would be very difficult to do. – IM PCP
• providers wish they had the automatic eGFR value prior
• providers feel the missed opportunity to help some patients by not having the
automatic value previously
• believe it to be a good clinical tool The ongoing reaction I’ve had [to the automatic reporting wishing I had known this a longtime ago. . . . It
just makes me think of all the stuff I wasn’t doing or keep track of before. - FM NP• helpful to have a more precise picture of renal health and CKD staging than just
creatinine could provide I find it is really helpful. I think it’s a useful tool to use as a reen. And I really think it’s an important item to
have on the problem list so that you pay attention when ’re prescribing. . . it becomes part of your decision
making if you’re going to moderate dosing of medication IM PCP
Increased Awareness It helps me when I review the charts for certain treatmen r just to get to know the patient. It makes me
aware that I can’t order certain medications. And it defini makes me aware that I should check it at regular
intervals to make sure I don’t miss when it starts trending wn. – IM PCP
• created more awareness of and attention to tracking CKD in general
• now know about and can manage all the patients provider did not know about before
automatic reporting began that have a “normal or slightly abnormal” creatinine and an
abnormal eGFR
Well, it’s made more awareness of chronic kidney disease. sort of opened up a whole new [population] of
chronic kidney disease patients. And it’s probably a more sitive number to follow, rather than the
creatinines. . .I can have a creatinine of 1.4 in one person th a normal GFR, and a creatinine of .9 with an
abnormal GFR - the GFR is simpler to pull. So ultimately I it better. - FM PCP• identified a pool of patients on providers’ panel with CKD status much worse than the
creatinine value alone was indicating – would not have “known” about these patients
or referred on to Nephrology without automatic reporting
Some of the patients who had a mildly abnormal creatin I’m now finding have a much more reduced GFR,
and that puts them in a higher stage of chronic kidney d se. And I am picking up a few of those that I
wouldn’t have known before and then referring them on. ’s just that it alerts me to the fact that their kidney
disease is worse than I might have suspected just from th vel of creatinine. – IM PCP
Improve Patient Care and Management It’s very much helped with the care of patients. I feel like I w what’s going on all the time now and I do a
better job. . .I feel like all the people I didn’t, you know, do ht by before - and that kind of kills me - I feel like I
give them good care finally. –FM NP
• overall provide better patient care by having the automatic eGFR value
• improves the ability of providers to assess and act on a patient’s renal health and
functioning earlier or to determine appropriate referral to Nephrology at earlier time
points
If there’s a low GFR but their creatinine is normal, I might ve ignored that before. . .[because] I thought [their
renal function] was normal. So that’s the major difference .because before if the creatinine was one, I might
not have ordered it for another year. Whereas now, if it re ts a low GFR I might order it more often, or start
adjusting the medicines. So I’m definitely ordering more te - FM PCP• greatly helps in medication management efforts, including determining both the
appropriate type and dosage of medication And the one thing that I feel it does do, if a patient goes a hospital, having GFR value [CKD stage] on the
problem list will protect him from somebody starting a da erous medication and monitor it more closely. . . I
want to optimize the person’s blood pressure. I want to o ize their sugar control. I want to be careful with
what medications I’m using. . . monitoring them with the R has more meaning than monitoring them with
the creatinine. So it’s nice to have it more available now. PCP
• having the more sensitive value of the eGFR, along with creatinine, helps give
gradation and refinement to patients’ renal health – helps provider determine “just
how bad” a patient may or may not be























































Table 3 Overall Impact of eGFR Automatic Reporting: Benefits and Challenges (n = 19) (Continued)
Challenges
Common Theme and Key Findings Illustrative Quotes
Patient Confusion / Fear Some patients were shocked – they were dismayed. They wanted to talk to me. I had some people who just
couldn’t understand, asking ‘What’s wrong with my kidneys?’. . . FM NP• initially caused some otherwise healthy patients concern and upset regarding
“suddenly” having a CKD diagnosis So, I think it caused distress and some fear because I never told them anything was wrong before, or I was
waiting until their creatinine got high before I figured it out. - FM PCP
• initially caused some otherwise healthy patients undue fear and stress regarding their
kidney health and future possibility of dialysis
It’s still a bit of an issue where there is that disconnect between some of the older patients who have a normal
creatinine but their GFR is in the chronic kidney disease range. So it generated for some patients’ questions,
concern, alarm that I think wasn’t really necessary. – IM PCP
Increase Provider Workload So basically, there might have been fifty or a hundred people who I had considered normal, who all of a sudden
had CKD3, by the GFR definition. So really, it’s more work, but if that’s the definition, then that’s the definition,
and it’s real. So I’ve made mechanisms to deal with it. – FM PCP
• initial reporting created a “new”, “unknown”, and “larger” pool of patients in Stage 3
that now needed outreach and follow-up
• initially created a “thinking” burden when trying to determine the correct e GFR value
on lab report – (both African American and Caucasian values reported)
I think the automatic reporting is an absolutely great idea. But, the actuality is we’ve got some problems with
how the computer reports it. . .I should not have to read every time the African and non-African American values
when the computer could somehow designate that. If we have race in our computer, it should be automatically
reported as the [correct] GFR and the computer should be estimating for the race. I shouldn’t have to be wasting
one second of time thinking about that. . .It hasn’t created clinical harm, but it’s just extra thought and extra
work for me. – IM PCP
• generated more follow up and tracking work for providers – another condition to now
follow and manage
• extra time and workload for provider to create their own systems and processes for
tracking, monitoring, and following up on patients eGFR values and renal health
Initially I felt there was a little confusion to patients around giving the limits of normal GFR, so that the patient
who was older could have a normal creatinine but an abnormal GFR, and the lab result would indicate chronic
kidney disease. And it just added a little extra problem of something you either had to explain to the patient, or
that they would ask questions about. . .I would usually then end up having to generate some sort of a letter
explaining it, rather than just sending out a copy of the lab report, which made more work for me. – IM PCP
• extra time and workload for provider to address patient fears and concerns regarding
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reporting some patients with a normal serum creatin-
ine were missed as having CKD. They said like the
reporting allowed them to identify those patients and
take appropriate action like referral to nephrology.
While it is recommended at KPNW that patients be
referred to a nephrologist when their eGFR falls below
30, there are no barriers to referral at any level of kid-
ney function. Clinicians reported improved patient
management because it allowed them to assess and act
on patient’s renal health at earlier stages than with
serum creatinine alone. Additionally they noted that
the appropriateness of medication and medication dos-
ing was improved. They also discussed organizational
financial improvements related to more accurate diag-
nosis, specifically Medicare.
Several concerns of eGFR reporting were also noted,
including patient confusion and increased clinician
workload. At KPNW it is common for patients to be
sent a record of their laboratory values, including auto-
mated eGFR reporting. Especially in the initial phase of
automated reporting, some patients ‘suddenly’ had kid-
ney dysfunction, causing patient confusion and some
anxiety over their health. For example, patients were
confused about the new information including seeing
two values of eGFR (one for black, and one for non-
black), and were also concerned about their risk of renal
dialysis. Addressing these patient concerns translated
into added workload for clinicians by necessitating
phone calls and explanatory letters to be sent. The dual
reporting of two values by race also caused a ‘thinking’
burden for clinicians since they were not able to simply
examine the eGFR value without also determining the
patient’s race. Perhaps the most important burden per-
ceived to clinician workload was that of adding another
disease to manage, because eGFR reporting revealed a
new and potentially quite large group of patients to man-
age. Allied Health providers reported being less likely to
incorporate a diagnosis of CKD into the patient’s health
record, and some clinicians reported creating systems to
monitor and track eGFR values for their patients.
Changes in work practices related to CKD management
Table 4 illustrates work practices findings influenced by
eGFR automated reporting, stratified by MD and allied
health clinicians. Approximately half (53%) of the clini-
cians reported they increased the amount of patient edu-
cation they provided following eGFR automated reporting.
Allied health practitioners and family practice MDs were
more likely to report this increase in patient counseling
and education than internal medicine MDs. Additionally,
68% of the clinicians noted the onset of eGFR automated
reporting created a need for designing and implementing
additional follow-up communication strategies in the formof specialized letters and telephone ‘talking points’ for
explaining eGFR results to their patients.
Most clinicians (74%) said that they had increased
their overall referrals to Nephrology, but only very
slightly. Four of the 13 physicians did not believe eGFR
automated reporting had any impact on their referrals,
as they still tended to manage and treat their patients up
to a later CKD stage of 4 prior to referring. However, all
the allied health practitioners reported a perceived in-
crease in referrals, and allied health practitioners were
more likely to refer at higher eGFRs (i.e. for less sick
patients) than physicians. Physicians divided evenly be-
tween referring at late CKD stage 3b and 4, while most
allied health reported referring to nephrology at earlier
CKD stage 3a. Slightly less than half the clinicians (47%)
reported ever referring to the HMO’s ‘kidney class’, a
dietician-led class aimed at helping patients take a
greater role in their kidney health; most clinicians said
their referral pattern to this class did not change with
eGFR reporting.
Suggestions to improve utilization of automated eGFR
reporting in clinical practice
The clinicians we interviewed had several suggestions
for improving the utilization of automated eGFR report-
ing, and for improving their overall CKD management.
Ongoing clinician education, using a case-study approach,
was noted as something they desired and suggested these
trainings could be made available both in-person and on-
line. They reported being especially interested in 1) why it
is better to use eGFR (versus serum creatinine), 2) how
eGFR should be used clinically at different CKD stages,
and 3) best ways to communicate to patients about their
eGFR at different CKD stages (Table 5).
Clinicians were also interested in hearing feedback, on
an on-going basis, from nephrology on their actions
related to CKD care. They particularly mentioned desir-
ing feedback on timing of nephrology referrals, ordering
of follow-up laboratory tests and the timing if these
tests, and clinical care they should be providing both be-
fore and after nephrology referral.
Other specific types of needs identified were related to
clinician tools and reminders. In the past, the HMO’s
department of nephrology supplied laminated 4″ × 6″
cards that summarized CKD guidelines and best practices.
Several clinicians, particularly allied health practitioners,
mentioned that they had found these helpful and would
like them updated and made available. Clinicians also
desired help with patient communication templates for
both letters and telephone scripts that could be used by
them and their medical assistants. They also mentioned it
would be helpful to have reminders of where to access
CKD guidelines and reminders of options for patient edu-
cation such as the aforementioned kidney class.
Table 4 Comparison of Work Practices Related to CKD Management since Automatic eGFR Reporting (n = 19)
Common Theme and Key Findings PCP Allied Totals Illustrative Quotes
(n = 13) (n = 6) (n = 19)
Patient Communication and Activation Activities If it is under 60, I tell the patient about what’s going spend time trying to educate the patient on that
and things to avoid to stay as healthy as possible. . .I talk to and counsel people more now than I ever
have before, on the NSAID usage or abuse. And it ma rrelate in terms of timing with that [automatic
reporting]. – IM PA
• increased counseling / education discussions with
patients about GFR value, kidney health, and CKD
management
6 (yes) 4 (yes) 10
7 (no) 2 (no) 9
I use the eGFR information quite a bit. . . have a conv tion when people need more information about
protecting their kidneys if they get down to a GFR be 0. So, if their cholesterol is high, give them
information about their cholesterol. If their GFR is low to get them to do some things to protect their
kidneys, etc. – FP PA
I am more aggressive about counseling for prevention kidney disease, now. . . I start talking with them
about making sure they’re getting plenty of water, av g caffeine, making sure their blood pressure is in
control, making sure they’re not on high protein diets t are more challenging for the kidney to filter, etc.
. . . and so just a lot of a more aggressive lifestyle cou ing for things that may maintain or maybe even
improve kidney function. – FP PCP
It depends on the patient and what I’m explaining, w er or not I go into it with them. Obviously, if they
ask me, then I tell them. Generally I don’t bring it up more how I practice what I’m doing. – IM PA
• created specialized letters and phone talking points for
explaining eGFR results and follow up activities to
patients
9 (yes) 4 (yes) 13 I send the patient a letter, using a dot phrase which d ibed the patient’s kidney function – explains that if
it’s a little bit off, it could be for many reasons, and th ften it is age and kidneys, but that at this point it’s
not concerning and we want to re-check in 3 month P NP
4 (no) 2 (no) 6
It does generate the need for additional information. e dot phrases that I use to explain GFR, just to let
them know the filtration rate and what that means. e dot phrases that explain where they can get more
information from the [National Kidney Foundation]– CP
So I have devised my own method that seems ration me. . .I have a dot phrase for when the creatinine
is normal, and the GFR is low and it says, ‘Your creati is normal but your GFR is low, sometimes this can
be due to diabetes or high blood pressure, and a lot es in three months it changes back to normal, so
let’s check it in 3 months. . .’ etc. – IM PCP
Overall Referral Patterns to Nephrology Yes, I am possibly referring more [to Nephrology]. . .I d have to say about 5 percent more, and chart
review is my first request. – IM PA• subtle increase (approx. 1 to 2 month) 8 6 14
It’s probably a subtle increase, because the informatio so clearly in your face, as a clinician you can just
see it. It would be hard to ignore, or hard to get distr and not pick it up, the way it’s reported. – NP IM
I think it has increased the number. . .probably once nth I’m referring someone - maybe once or twice a
month - to the nephrologist. . .for a face to face or ch review, it varies. –FP PCP
It has some because. . . once it gets down towards th then I’ll refer them to Nephrology to take a look at
it. And sometimes if I’m really not sure and it’s getting ser and I’m worried about something or other, I’ll
have the nephrologist do a chart review. – IM PCP
• no perceived increase in referrals 4 0 4 It’s not had much impact on my referral to nephrolog cause usually I don’t refer unless it gets much lower
than that. So for the mildly decreased GFR’s of 45 to nge, I’m still managing it. – FP PCP
No, I don’t refer more. . . I just treat them. They only o that get a chart review are the Stage Fours. And
they’re not that many of those. – IM PCP
• believe referrals have decreased 1 0 1 I’ve probably cut down the number of referrals to Nep ogy. . . I don’t know that I referred a lot before the
change, but I would say in general probably it’s reduc he amount of referrals because I can monitor more,




















































Table 4 Comparison of Work Practices Related to CKD Management since Automatic eGFR Reporting (n = 19) (Continued)
Typical GFR Referral “Cut-off” Values Well, it’s probably when it gets down closer to 40 or below I’m more likely to do a referral to Nephrology and
specify a chart review. . . .If it’s hovering around 60, or if it’s in the mid-fifties, I don’t feel so compelled to do
anything about it, right then, except to make sure that the patient gets rechecked again in 6 months, or
something. – IM NP
• eGFR value low 40’s to 40 1 4 5
I believe it’s 40 or 45, is the cutoff point between seeing the Nephrologist or not. . . if it’s in that 40 range or
so, then usually I go ahead and refer at some point. Usually I follow them for at least a few months and
have done the other lab work and ultrasound within that timeframe. – FP PCP
• eGFR value 35 or less 4 0 4 Well, the nephrologists have said [to refer for] a GFR for less than 35 . . .So I do. Period. But I have patients
who don’t quite make that. . ..clearly, somebody who has a big jump, without a reason for it, [needs] to have
a conversation with the nephrologist, or a referral to the nephrologist. - FP PCP
If in the CKD3 range then just continuing the counseling, lifestyle modifications, and monitoring. And then if
it’s dipping into the CKD4 where they’re down in that like 15 to 30 range, I’m thinking renal referral [to
Nephrology]. – FP PCP
• eGFR value 15 to 30 4 0 4 When they get down to the twenties or especially below, then I usually will refer. Or if they may be Stage 3,
but for some reason they seem to be dropping rapidly. . . Although, usually I’ll work those up first myself. I’ll
get an ultrasound and recheck them, and maybe take them off some possible medications and then see
what happens. I do all that first, and only if nothing budges . . ., I usually then ask for a referral. – IM PCP
• Base it on creatinine not eGFR 0 1 1 So I don’t refer or ask for chart review from nephrology when eGFR is under 60 though. . .As far as referral,
the threshold is probably closer to 2 on a creatinine. So I use creatinine in that respect. – IM PA
• did not offer typical cut-off value (based on trends over
time)
4 1 5 I probably don’t have a set number, because it would depend on the whole picture of the patient I want to
know if this is a new occurrence or if this is a trend. Is this particular patient a diabetic? If it’s an acute new
problem, I would treat it differently than if it’s a chronic ongoing problem. – FP PA
Well, rather than a number, it is a trend. . . for a patient I’d be looking back and if he or she hadn’t changed
much in a year, I wouldn’t be referring.–IM PCP
Overall Referral Patterns to Kidney Class I definitely refer more to the class. . .I like them to go to the kidney class to learn more about how to protect
their kidneys. – FP PA• refer more to class now 1 1 2
• refer infrequently to occasionally 4 3 7 When people are anxious, I will refer to the class for reassurance purposes and education. But I don’t send a
high percentage of patients to that class, and I don’t take advantage of that resource as often as I could. –
IM PA
I’m aware of it, and I might have referred one person in the past couple of years but usually it’s for the lower
GFR’s – like a low 30 – to have them look at their diet and things. But so far I haven’t used that class that
much. – FP PCP
• never refers to class 2 0 2 I’ve never referred to the kidney class myself. I have the impression that patients who go to kidney class are
really the ones who already saw the nephrologist, or if they [Nephrology] advise me in a chart [consult]. . . -
IM PCP



















Table 5 Suggestions for Future Needs to Improve Utilization of eGFR Value and Overall CKD Management (n = 19)
Common Theme and Key Findings Illustrative Quotes
Ongoing Provider Education It would be nice to get a little lecture on it, an talk to a nephrologist one-on-one. . . Or if they
could do it, they could make one of those DV ds of things and you can tune in or watch at
home. - IM PCP
• yearly trainings both in-person and on-line
• trainings to focus on: why use eGFR; how to best use it at different states/values; how to best
communicate and educate patients at different values/stages
I’d like to know if the eGFR so sensitive that it g to give some false positives, what’s the rate of
those that are occurring? And how does our c uter monitoring systems handle that. . . I would like
to know more about that. – NP IM
• provide case-study approach highlighting different patient scenarios A good topic to have at one of our CME pres ions would be a talk about it in a very case study
practical sense; not as a lecture . . .but more l kay, let’s look at this person. . . And just talk us
through it, how it’s useful - just the practical u GFR versus BUN, creatinine in a pure sense – that
would be helpful. . .. – FP PA
• provide both opportunity and responses to provider questions/concerns
Regular Feedback from Nephrology to PCPs So there still are questions around what do w s by just getting a UA and an ultrasound? Is there
something more we’re missing, before we sen m to the nephrologist and they go on dialysis?
What if we’re missing a multiple myeloma or litis, which can be treated before they were sent to
the nephrologist. . . .that’s the type of question ve, ‘Are we getting everything with that UA and the
baseline ultrasound?’ – IM PCP
• Provide yearly to twice yearly feedback on the provider’s actions related to such things as:
→ referral patterns to Nephrology appropriately – is it too much or coming too late
The Nephrology Department can see the refer oming in, so they can see how providers, in general,
[treat] kidney disease. Are we reasonable with eferrals?. . .Are we sending people too early or too
late? It would be nice to know are there place ere there’s room for improvement. I want to know
whether I’m doing a reasonable job or not. – P
→ ordering patterns for follow up labs and tests - are the appropriate labs and tests being
ordered at the appropriate times
→ identification of whether there is anything else the provider could be doing for the patient
both prior to and after referral to Nephrology
If it’s [eGFR] in the fifties, should I monitor it e months? In the forties, should I monitor it every 4
months? I don’t really know how often I shou monitoring the GFR. And then, when am I
supposed to do any other evaluation for their eys? . . .I’m not sure when I’m supposed to do theses
other follow up tests. – FP PA
Development of Provider Tools/Reminders I had a nice little, laminated handout that ca om Nephrology on guidelines and referrals. It has
now gone missing, so it would be helpful to h hat resent out again – it’s a very convenient and
worthwhile thing to have. - PA IM
• update and re-send out laminated card summarizing current CKD guidelines and “best practice”
referral patterns based on eGFR value
I guess I would like a dot phrase*. What shou ll these people? What does Nephrology want us to
tell people with CKD? . . .So having a created hrase would be wonderful to put on the results to
the patient, explaining what to expect and wh come back . . . - FM NP
• create several different letter templates and phone scripts (based on eGFR value and CKD
staging) for use by providers and medical assistants in their discussions and communication with
members
It might be really worthwhile to just reorient p , maybe once a year, with an email saying, this is
why we’re doing eGFRs, we’ve got physic phys support accompanying that EGFR process, here is
what we hope to end up doing with the data here’s how we manage those populations of
people that are getting chronic kidney disease NP
• yearly reminders of where to access CKD guidelines on-line, and any changes in the guidelines
• yearly reminders of the Kidney class option, including where, when, and how often it occurs and
the appropriate circumstances to refer patients to class
My suggestion would be to offer another quic in the clinical practice guidelines to take you there
to quickly find CKD guideline information. – F
I’d love to see a promotion about the kidney c so that clinicians are more aware of it. . . . if they’d
promote the kidney class and say, in general classes are offered at[these] various times and
locations, etc. -. that would help primary care use we inevitably get those types of questions. – FP
PCP
Improved Integration of GFR values into EMR/Other Web-based Tools In primary care, we’ve set up this thing called ant Results. It can show up either on our scheduled
page or when we open the patient’s chart. It the trend of three things, but we don’t have the
GFR there. We just have the creatinine. . . it w be nice and helpful to have the GFR there as well. –
FM PCP
• consistent, automatic process for eGFR value and follow ups to be reported in commonly used





















































Table 5 Suggestions for Future Needs to Improve Utilization of eGFR Value and Overall CKD Management (n = 19) (Continued)
I would like a “decreased GFR” option for the problem list. . . When I put a problem in the problem list,
I just have to pick something that is close to what I want, so for this I’ve chosen the ‘elevated
creatinine’ option as a flag, but what I really want is a ‘decreased GFR’ option. -FM NP
• improve ability of computer to correctly impute race so providers and patients see only one
eGFR value rather than both on lab results, outreach prompts, or patient letters
• continue to improve and refine smart set tools in the internal referral process of EMR to facilitate
proper lab orders and follow up by providers
Patient-Related Education Tools On the subject of kidney health, I would like some models, pictures, charts, those sorts of things that
would be useful in discussion with patient - something that that you could use to pin to your wall
and say, ‘Now here’s what a kidney looks like and this is the problem with the low GFR’, for example. –
IM PA
• create standard, uniform hand-outs for providers to use with patients to help explain kidney
functioning, meaning of eGFR values, and CKD staging
• create visual exam room posters of the kidneys and how they function to assist with provider
communication and education to patients
I try to say to patients their kidneys aren’t failing, they’re just not functioning optimally. That part I
don’t have worded right, because some of them tend to freak out about it, so I would like some help
with wording that, and how to explain that to them. . .if we could just give them a packet, I think if
they would read that, that might be helpful. But the wording, I would like some help with that,
because I don’t seem to quite get that right. - FP PA
• improve patient information and education about CKD and kidney functioning on the
organization’s external website
I would love to have a chronic kidney disease patient handout that gives the basic information. It
would be good if we had a specialist-created, kind of supervised handout that we can give to patients
that says, ‘Here’s what you should do to control your blood pressure, your diabetes if you have it;
avoiding these substances that can be harmful to the kidneys. And here’s what you should do for
nutrition, protein intake, water intake, etcetera’. And have that kind of be standardized. . . And that
information could then also be easily found by patients online at KP.org, so if they’re looking for CKD
information it is there online as well. – FP PCP
* dot phrase: an electronic medical record tool of pre-populated, standardized text that a provider can automatically insert into such things as letters, after visit summaries, and lab results for patient viewing. Dot



















Smith et al. BMC Nephrology 2012, 13:154 Page 12 of 13
http://www.biomedcentral.com/1471-2369/13/154Clinicians had several suggestions for the integration
of the eGFR reporting into the EMR. Some of these sug-
gestions had to do with reminders to obtain follow-up
laboratory measures, perhaps incorporated into patients’
diagnosis list, in the laboratory values reports, and in the
section of the EMR that reports trended laboratory
values. They also discussed the need to address the con-
fusion over the eGFR report containing two values that
depend on race. Clinicians also expressed a desire to see
improvements in the ability of the EMR to facilitate ap-
propriate laboratory orders and follow-up, for example
through ‘smart sets’ that automatically allow a pended
order for future laboratory kidney-related tests.
The clinicians we interviewed were also keen to see
more patient related education tools, including handouts
that explain kidney function, the meaning of eGFR and
CKD staging. They said exam room posters of kidney
function could facilitate communication with patients,
and that the HMO’s external website could be used to
improve communication about kidney health.
Discussion
We found that clinicians were aware of eGFR reporting
and generally held favorable views toward it, but also
noted some barriers to its use. Perhaps the most inter-
esting theme that emerged from our interviews was that
eGFRs were not used to replace serum creatinines, but
were used as an added source of information. Clinicians
used eGFR as a tool to help: 1) identify CKD; 2) educate
patients about their kidney function and; 3) make treat-
ment decisions. The clinicians we interviewed suggested
that the added gradation provided by eGFR allowed
them to identify CKD at earlier stages than serum cre-
atinine alone, but for most of the clinicians we inter-
viewed the eGFR did not replace serum creatinine as an
indication of later staged kidney disease.
It appears from clinician responses that serum creatin-
ine is used as a means of validating eGFR measures.
While this may seem redundant, it may be entirely ap-
propriate. Though serum creatinine overestimates renal
function when it is poor, eGFR underestimates renal
function when it is normal [7,24]. A number of com-
ments by the clinicians we interviewed highlight that
concern. Undue stress and fear expressed by patients
and the increased burden of tracking patients who may
have normal kidney function seem likely to be the result
of GFR underestimation. This finding may help confirm
prior efforts to measure the cost/effectiveness ratio of
eGFR reporting which have found that while eGFR may
be beneficial to patients with CKD the benefit was offset
by false positive diagnoses of CKD [25], At KPNW we
have subsequently switched to the CKD-EPI formula
which reduces the effect of underestimation of GFR at
normal and near normal levels.Reporting of eGFR has seemingly created a greater
awareness of kidney dysfunction among the clinicians
we interviewed. This is a significant finding because that
enhanced awareness highlights shortcomings in clinician
education; in fact, suggestions made by the clinicians we
interviewed to improve utilization of eGFR value
revolved primarily around clinician education. Inter-
action between nephrologists and primary care physi-
cians would appear to play an important role in how
eGFRs are utilized. KPNW has made efforts to educate
primary care clinicians (CME conferences, written litera-
ture, guidelines embedded in the EMR), and the message
from our study illustrate that ongoing educational efforts
are important. It may also suggest that, because busy
primary care clinicians can’t always avail themselves of
these opportunities, it is incumbent on the system to ad-
vertise the educational opportunities widely, on an on-
going basis, and offer several venues to accommodate
varied learning and practice styles. The need for clinician
education is likely to be greater in other medical systems
that have not undertaken similar efforts.
Our study was qualitative, meaning it lacks the empiric
information necessary to discern whether the responses
represented the feelings of clinicians across the Kaiser
Permanente system, or whether they can be extrapolated
to other clinicians and medical systems. For example,
our findings are specific to a health system with an ex-
tant, fully functioning EMR. Such a system may allow
clinicians more immediate access to ancillary informa-
tion (e.g. guidelines) about eGFR interpretation, perhaps
easing the transition. The opinions expressed may have
been different if the interviews were conducted by a dif-
ferent interviewer or if solicited by another means (i.e. a
survey). Additionally, our modest number of interviews
may yield less stable frequency estimates than if we had
access to a larger sample. But strengths of our approach
include the use of a pre-specified interview guide, use of
trained interviewers, and interviewing to “saturation”.Conclusion
The manner in which clinicians use eGFRs appears to be
more complex than previously understood, and our
study illustrates some of the efforts that might be use-
fully undertaken (e.g. specific clinician education) when
encouraging further promulgation of eGFR reporting
and usage.
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